Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 89
Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities
Hasan Nassereldine, Kelly Compton, Parkes Kendrick, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 3, pp. e186-e198
Open Access | Times Cited: 10
Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
Jian‐Dong Li, Yanxin Hu, Jiayao Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Schnellschnitt in der hepatobiliären Chirurgie
Sven Arke Lang, Lara R. Heij, Jan Bednarsch, et al.
Deleted Journal (2025)
Closed Access
Assessment of intrahepatic cholangiocarcinoma with LI-RADS in the high-risk population: MRI diagnosis and postoperative survival
Ruofan Sheng, Beixuan Zheng, Yunfei Zhang, et al.
Cancer Imaging (2025) Vol. 25, Iss. 1
Open Access
Exosome-transmitted circ_002136 promotes hepatocellular carcinoma progression by miR-19a-3p/RAB1A pathway
Peng Yuan, Jinhua Song, Fei Wang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
Michele Montori, Chiara Scorzoni, Maria Eva Argenziano, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6498-6498
Open Access | Times Cited: 16
Triptolide inhibits intrahepatic cholangiocarcinoma growth by suppressing glycolysis via the AKT/mTOR pathway
Li Li, Chuting Wang, Zhenpeng Qiu, et al.
Phytomedicine (2022) Vol. 109, pp. 154575-154575
Closed Access | Times Cited: 14
Differential diagnosis of different types of solid focal liver lesions using two-dimensional shear wave elastography
Jia Guo, Dong Jiang, Yi Qian, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 32, pp. 4716-4725
Open Access | Times Cited: 9
Multilayered insights: a machine learning approach for personalized prognostic assessment in hepatocellular carcinoma
Zhaohan Zhang, Yunxiang Du, Shuzhen Wei, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 1
Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
Jianbo Peng, Shuo Fang, Meisheng Li, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Trends in Liver Cancer Incidence and Survival in Italy by Histologic Type, 2003–2017
Silvia Mancini, Lauro Bucchi, Federica Zamagni, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6162-6162
Open Access | Times Cited: 6
Ethnic disparities in the epidemiology, treatment, and outcome of patients with hepatocellular carcinoma in the United States
Mohammad Saeid Rezaee-Zavareh, Jeff Liang, Ju Dong Yang
Hepatoma Research (2023) Vol. 9, pp. 10-10
Open Access | Times Cited: 3
Unique Morphologic Findings in the Liver After Stereotactic Radiation for Cholangiocarcinoma
Gwyneth Shook Ting Soon, Saba Yasir, Tsung-Teh Wu, et al.
The American Journal of Surgical Pathology (2023) Vol. 47, Iss. 7, pp. 792-800
Closed Access | Times Cited: 2
Multimodality imaging of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Haneyeh Shahbazian, Mohammad Mirza‐Aghazadeh‐Attari, Ali Borhani, et al.
Journal of Surgical Oncology (2023) Vol. 128, Iss. 4, pp. 519-530
Closed Access | Times Cited: 2
Percutaneous transhepatic cholangiography: An effective option for endo-biliary radiofrequency ablation before stent insertion in unresectable biliary cancer?
Dimitrios Karagiannakis
World Journal of Clinical Cases (2024) Vol. 12, Iss. 30, pp. 6413-6416
Closed Access
Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma
Jie-Zhuang Huang, Jian‐Di Li, Gang Chen, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 1, pp. 62-88
Open Access
Site-specific N-glycan alterations on haptoglobin as potential biomarkers for distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma
Didi Liu, Jun Li, Yue Xue, et al.
International Journal of Biological Macromolecules (2024), pp. 135563-135563
Closed Access
Establishment and Characterization of Three Gemcitabine-Resistant Human Intrahepatic Cholangiocarcinoma Cell Lines
Jian‐Dong Li, Yanxin Hu, Jiayao Zhang, et al.
Research Square (Research Square) (2024)
Closed Access
Neutrophil plasticity in liver diseases
Jia Ming Nickolas Teo, Weixin Chen, Guang Sheng Ling
Journal of Leukocyte Biology (2024)
Closed Access
Frequency distribution and ten-year survival rate of patients with different malignant liver lesions in Iran ‎
Seyed Mohammadreza Mortazavizadeh, Sareh Rafatmagham, Fahimeh Tabatabaie, et al.
Journal Of Advanced Pharmacy Education And Research (2022) Vol. 12, Iss. 2, pp. 71-75
Open Access | Times Cited: 2
Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study
Shuai Hao, Rongkun Luo, Wei Li, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access
Page 1

Scroll to top